Details of the Drug Reposition

General Information of This Drug (ID: DMHPME3)

Drug Name
PMID18163548C4   DMHPME3
Synonyms 7IN; 1vja; AC1L9MNX; GTPL6545; BDBM50231520; US8476306, 6.12
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myocardial ischemia DISFTVXF BA6Z Clinical trial [1]
Reperfusion injury DISVJQ2R ND56.Z Clinical trial [1]
------------------------------------------------------------------------------------

References

1 Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator. J Med Chem. 2008 Jan 24;51(2):183-6.